StopDown
Funding · 9 January 2025Innovaccer$275MHealthcare AI and data platform

Innovaccer raises $275M in Series F round

By · Editor ·

Series FSan FranciscoFounded 2014
  • Innovaccer builds a healthcare AI platform that unifies patient data across electronic health records, insurers, and labs
  • It raised $275 million in Series F funding led by Kaiser Permanente, with participation from B Capital Group and others
  • The company plans to use the funds to expand AI capabilities and target an IPO after reaching $400M-$500M in annual recurring revenue

What happened

  • Innovaccer raised $275 million in a Series F round that included both primary and secondary components.
  • Approximately 35% of the funds were allocated for liquidity to seed and Series A investors.
  • The post-money valuation for the primary funding is around $3.45 billion, according to a source familiar with the matter.
  • The round was led by Kaiser Permanente, with participation from B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, and M12 (Microsoft's venture fund).
  • The company has raised a total of $675 million to date.
  • Innovaccer plans to use the funds to expand customer collaboration, introduce new AI and cloud capabilities, and scale its developer ecosystem.
  • The company targets an IPO after reaching $400 million to $500 million in annual recurring revenue.

Why it matters

  • Innovaccer spent about two years and over $100 million building electronic health record connectivity.
  • The company has grown revenue 50% year-over-year for the past five years.
  • It is on track to hit $250 million in annual recurring revenue this year.
  • Innovaccer acquired Cured (a healthcare CRM platform) and Pharmacy Quality Solutions (performance measurement tools) in the past year.

The business

  • Innovaccer provides a healthcare AI platform that unifies patient data across electronic health records, insurers, pharmacies, and labs.
  • Its platform is called the Innovaccer Health Cloud or Healthcare Intelligence Cloud.
  • Products include value-based care, population health management, CRM, and AI copilots for clinical decision support, clinical documentation, care management, contact centre, utilisation management, prior authorisation, an AI medical scribe, and a denied claims tool.
  • It serves over 130 healthcare organisations, including six of the top 10 US health systems.
  • Named customers include Orlando Health, MercyOne, CommonSpirit Health, and Kaiser Permanente.
  • Public sector partnerships include San Mateo County and Alameda County.
  • India revenue was Rs 397 crore in FY23, with a profit of Rs 37 crore.
  • The company targets profitability by the first half of FY25.

The founders

Abhinav Shashank

Co-founder and CEO

Sandeep Gupta

Co-founder and COO

Kanav Hasija

Co-founder

Who put in money

In numbers

$675MTotal raised to date · 2025
$150MAnnual recurring revenue run rate · 2024
50%Revenue growth (YoY) · 2024
Rs 397 croreIndia revenue · FY23
Rs 37 croreIndia profit · FY23

What happens next

  • Expand customer collaboration and introduce new AI and cloud capabilities.
  • Scale the developer ecosystem.
  • Target an IPO after reaching $400M-$500M in annual recurring revenue.
  • Achieve profitability by the first half of FY25.
  • Develop AI solutions in-house and through partnerships or acquisitions.

Earlier rounds

  • December 2021 · Series E · $150M · led by Mubadala Capital

Up against

OptumHealth CatalystSalesforce

Words to know

Series F
A late-stage funding round, typically for companies that are mature and may be preparing for an IPO.
Primary and secondary components
Primary means the company issues new shares to raise money; secondary means existing shareholders sell their shares, so the money goes to them, not the company.
Annual recurring revenue (ARR)
The yearly value of a company's subscription-based revenue, used to measure predictable income.
Population health management
A healthcare approach that uses data to improve the health outcomes of a group of patients, often by identifying risks and coordinating care.

The numbers around it

Innovaccer has 3 funding rounds in StopDown's archive, $675 million raised in all.

#The numbers around it
WhenRoundAmountLed by
15 December 2021Series E$150MMubadala Capital
15 February 2021Series D$105MTiger Global Management

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • IPO: An IPO, or initial public offering, is the first time a company sells its shares to the public and lists on a stock exchange. In India SEBI supervises it and the shares trade on the NSE and BSE. A retail investor can bid up to ₹2 lakh, and the issue stays open for three working days.
  • ARR and MRR: MRR is the monthly recurring revenue a company expects from subscriptions, and ARR is that figure times twelve. They suit software and subscription companies only. ARR is a run rate, not booked revenue, so ARR claims in Indian news can differ from filed accounts.

Everything on Innovaccer → · All startup news on 9 January 2025 →

Is this Innovaccer? Get your “Featured on StopDown” badge →